Podcast


Presenter: Adrienne J Lindblad BSP ACPR PharmD G. Michael Allan MD CCFP James McCormack BSc(Pharm) PharmD

Podcast: BS Medicine Episode #489: Mission Slimpossible – Semaglutide for weight loss
0:00

In episode 489, Mike and James invite Adrienne to go over the evidence for weight loss with semaglutide. We find the evidence shows that weight loss is on average roughly 10 kg over the effect of placebo, however this comes at the expense and inconvenience (injection) of the medication and roughly 25% of people (over…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here



CFPCLearn Logo

Listening to the Podcast can earn you MainPro+ Credits

Join Now

Already a CFPCLearn Member? Log in



Latest Podcasts

BS Medicine Episode #624: PCSK9 Inhibitors: Cardiovascular prevention panacea or pricey pokes?

In episode 624, James and Mike K invite Tony Nickonchuk to go over all the new evidence we have for the PCSK9 inhibitors. First, we discuss whether or not the…
Listen 0.5 credits available

FM Rounds #20: Accompagner les personnes trans et non binaires en médecine familiale

Le groupe d'intérêt des membres sur la santé des patients 2SLGBTQ+ a collaboré avec projet NUANCES, centre de soins en diversité sexuelle et de genre. Dre Judith Lajeunesse et Charlotte…
Listen 0.5 credits available

FM Rounds #19: Coming Home: Post-op Gender Affirming Surgery in Primary Care

This podcast discusses two of the most common gender-affirming surgeries - vaginoplasty in a transfeminine patient and top surgery or mastectomy in a trans masculine patient. These are emotionally high…
Listen 0.5 credits available

Presenter(s):

Adrienne J Lindblad BSP ACPR PharmD G. Michael Allan MD CCFP James McCormack BSc(Pharm) PharmD

This content is certified for MainPro+ Credits, log in to access


Presenter(s):

  • Adrienne J Lindblad BSP ACPR PharmD
  • G. Michael Allan MD CCFP
  • James McCormack BSc(Pharm) PharmD

Speakers do not have any conflicts of interest to declare.